CYP27A1 and osteoporosis: A systematic review of teriparatide (SC 20 μg/day) for treatment of Asian patients with osteoporosis at high risk for fracture, shows a sustained increase in bone formation markers (PINP, BAP) and bone resorption markers (CTX-I, NTX-I) [44].